Efficacy, safety and variability in pharmacotherapy for adults with attention deficit hyperactivity disorder: a meta-analysis and meta-regression in over 9000 patients

[1]  S. Dalsgaard,et al.  Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study , 2015, The Lancet.

[2]  G. Salum,et al.  Annual research review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. , 2015, Journal of child psychology and psychiatry, and allied disciplines.

[3]  R. Cunill,et al.  Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence , 2015, Journal of psychopharmacology.

[4]  M. Srisurapanont,et al.  Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD , 2014, Drug design, development and therapy.

[5]  J. Bae.  Meta-epidemiology , 2014, Epidemiology and health.

[6]  J. Bae.  Methodological issues for determining intervals of subsequent cancer screening , 2014, Epidemiology and health.

[7]  P. Asherson,et al.  Efficacy of atomoxetine in adults with attention deficit hyperactivity disorder: An integrated analysis of the complete database of multicenter placebo-controlled trials , 2014, Journal of psychopharmacology.

[8]  D. Nutt,et al.  Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology , 2014, Journal of psychopharmacology.

[9]  C. Correll,et al.  Efficacy and safety of atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: results from a comprehensive meta-analysis and metaregression. , 2014, Journal of the American Academy of Child and Adolescent Psychiatry.

[10]  Hugo Peyre,et al.  15. CADDRA. Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA). 3rd ed. Toronto, ON: Canadian ADHD Practice Guidelines; 2011. , 2014 .

[11]  T. Epstein,et al.  Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults. , 2014, The Cochrane database of systematic reviews.

[12]  M. Farré,et al.  Efficacy of psychostimulant drugs for amphetamine abuse or dependence. , 2013, The Cochrane database of systematic reviews.

[13]  F. Castellanos,et al.  Clinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years later. , 2012, Archives of general psychiatry.

[14]  R. Weisler,et al.  Randomized Clinical Study of a Histamine H3 Receptor Antagonist for the Treatment of Adults with Attention-Deficit Hyperactivity Disorder , 2012, CNS Drugs.

[15]  E. Willcutt.  The Prevalence of DSM-IV Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review , 2012, Neurotherapeutics.

[16]  S. Faraone,et al.  Adult outcome of attention-deficit/hyperactivity disorder: a controlled 16-year follow-up study. , 2012, The Journal of clinical psychiatry.

[17]  U. Müller,et al.  Systematic review of national and international guidelines on attention-deficit hyperactivity disorder , 2012, Journal of psychopharmacology.

[18]  R. Baldessarini,et al.  Randomized, Placebo-Controlled Trials of Antidepressants for Acute Major Depression: Thirty-Year Meta-Analytic Review , 2012, Neuropsychopharmacology.

[19]  E. Willcutt,et al.  The Prevalence of DSM-IVAttention-Deficit / Hyperactivity Disorder : A Meta-Analytic Review , 2012 .

[20]  George I Papakostas,et al.  Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials. , 2011, The Journal of clinical psychiatry.

[21]  M. Srisurapanont,et al.  Bupropion for adults with attention‐deficit hyperactivity disorder: Meta‐analysis of randomized, placebo‐controlled trials , 2011, Psychiatry and clinical neurosciences.

[22]  Isabelle Boutron,et al.  Single-Center Trials Show Larger Treatment Effects Than Multicenter Trials: Evidence From a Meta-epidemiologic Study , 2011, Annals of Internal Medicine.

[23]  G. Unwin,et al.  Scales for the identification of adults with attention deficit hyperactivity disorder (ADHD): a systematic review. , 2011, Research in developmental disabilities.

[24]  David Rigau,et al.  Efficacy of Methylphenidate for Adults with Attention-Deficit Hyperactivity Disorder , 2011, CNS drugs.

[25]  Marc J. Diener,et al.  Dropout and therapeutic alliance: a meta-analysis of adult individual psychotherapy. , 2010, Psychotherapy.

[26]  Michael Fitzgerald,et al.  European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD , 2010, BMC psychiatry.

[27]  R. Kilian,et al.  Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder , 2009, Journal of psychopharmacology.

[28]  Mark S Levenson,et al.  Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration , 2009, BMJ : British Medical Journal.

[29]  S. Bálint,et al.  Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis , 2009, British Journal of Psychiatry.

[30]  R. Klein,et al.  Lifetime criminality among boys with attention deficit hyperactivity disorder: A prospective follow-up study into adulthood using official arrest records , 2008, Psychiatry Research.

[31]  Rodney J. Moore,et al.  Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response. , 2008, The American journal of psychiatry.

[32]  M. McDonagh,et al.  Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis , 2008, Psychopharmacology.

[33]  S. Evans,et al.  Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo. , 2007, Drug and alcohol dependence.

[34]  L. Jerome,et al.  What we know about ADHD and driving risk: a literature review, meta-analysis and critique. , 2006, Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent.

[35]  M. Wasdell,et al.  Effectiveness outcomes in attention-deficit/hyperactivity disorder. , 2006, The Journal of clinical psychiatry.

[36]  L. Hechtman,et al.  A randomized double-blind trial of paroxetine and/or dextroamphetamine and problem-focused therapy for attention-deficit/hyperactivity disorder in adults. , 2006, The Journal of clinical psychiatry.

[37]  Joseph Biederman,et al.  Functional impairments in adults with self-reports of diagnosed ADHD: A controlled study of 1001 adults in the community. , 2006, The Journal of clinical psychiatry.

[38]  R. Kessler,et al.  The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. , 2006, The American journal of psychiatry.

[39]  E. Nunes,et al.  Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo. , 2006, Drug and alcohol dependence.

[40]  Mats Johnson,et al.  Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorder , 2006, European Child & Adolescent Psychiatry.

[41]  S. Faraone,et al.  A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder , 2005, Biological Psychiatry.

[42]  J. Swanson,et al.  National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. , 2004, Pediatrics.

[43]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[44]  J. Lieberman,et al.  The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. , 2003, Schizophrenia bulletin.

[45]  I. Shoulson,et al.  Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children , 1999, Clinical pharmacology and therapeutics.

[46]  C S Berkey,et al.  A random-effects regression model for meta-analysis. , 1995, Statistics in medicine.

[47]  C. Begg,et al.  Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.

[48]  W. G. Cochran.  The combination of estimates from different experiments. , 1954 .